MoneyWorks4Me

Bliss GVS Pharma informs about disclosure of related party transactions

10 Jun 2021 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Bliss GVS Pharma has informed that it enclosed disclosure of Related Party Transactions on the basis on consolidated financial statements for the half year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1857.45
Dr. Reddys Labs. 1150.80
Cipla 1355.70
Lupin 2052.35
Zydus Lifesciences 1107.95
View more..